Prestigous West Coast Academic Medical Center Renews Six-Figure, Multi-Year Agreement For Privacy And Security Managed Services.
July 19 2022 - 7:00AM
Business Wire
CynergisTek to provide its flagship Compliance Assist Partner
Program (CAPP) and Vendor Security Management (VSM) services to
leading Academic Medical System
CynergisTek, Inc. (NYSE American: CTEK), leading cybersecurity,
privacy, compliance, and IT audit firm helping organizations in
highly regulated industries navigate emerging security and privacy
issues, announces a multi-year extension with a 500+ bed, academic
medical center in California. Through this ongoing partnership,
CynergisTek will provide this client with its signature Compliance
Assist Partner Program (CAPP) service. This service is designed to
provide consistent engagement through cybersecurity managed
services such as an enterprise risk assessment, advisory services,
interoperability security controls assessment, penetration testing,
medical device assessment, and Vendor Security Management to assess
and report on third-party risk.
CynergisTek’s team of experts will continue to assist this
client in strengthening its overall risk management program,
meeting compliance requirements, and achieving its goal of
improving the overall maturity of its cybersecurity controls.
“We are excited about this long-term partnership because it
allows us to demonstrate our value as an extension of our
customers’ cybersecurity, privacy, and compliance teams. We look
forward to continuing our partnership on the journey to increase
the maturity of their cyber risk program, in an impactful way by
assessing, validating, and advising on cybersecurity threats and
helping to strengthen their programs as a whole,” said Dave Bailey,
VP of Security Services at CynergisTek.
“This renewal marks more than a decade of service to this great
institution and demonstrates the strong enduring partnerships we
seek to build with our clients. Over the past 10 years working with
this organization we have seen them invest significantly in
improving their security posture and culture. This kind of
organization wide commitment and effort to build a proactive
program makes them the kind of partner we enjoy working with and
serving,” said Mac McMillan, CEO of CynergisTek.
About CynergisTek, Inc.
CynergisTek is a top-ranked cybersecurity consulting firm
helping organizations in highly-regulated industries, including
those in healthcare, government, and finance navigate emerging
security and privacy issues. CynergisTek combines intelligence,
expertise, and a distinct methodology to validate a company's
security posture and ensure the team is rehearsed, prepared, and
resilient against threats. Since 2004, CynergisTek has been
dedicated to hiring and retaining experts who bring real-life
experience and hold advanced certifications to support and educate
the industry by contributing to relevant industry associations. For
more information, visit www.cynergistek.com or follow us on Twitter
or LinkedIn.
Cautionary Note Regarding Forward-Looking Statements
This release contains certain forward-looking statements
relating to the business of CynergisTek. These forward-looking
statements are within the meaning of Section 27A of the Securities
Act of 1933, as amended (the “Securities Act”) and Section 21E of
the Securities Exchange Act of 1934, as amended (the “Exchange
Act”) and can be identified by the use of forward-looking
terminology such as “believes,” “expects,” “anticipates,” “would,”
“could,” “intends,” “may,” “will,” or similar expressions. Such
forward-looking statements involve known and unknown risks and
uncertainties, including but not limited to uncertainties relating
to product/services development; long and uncertain sales cycles;
the ability to obtain or maintain proprietary intellectual property
protection; future capital requirements; competition from other
providers; the ability of the Company’s vendors to continue
supplying the Company with supplies and services at comparable
terms and prices; the Company’s ability to successfully compete and
introduce enhancements and new features that achieve market
acceptance and that keep pace with technological developments; the
Company’s ability to maintain its brand and reputation and retain
or replace its significant customers; cybersecurity risks and risks
of damage and interruptions of information technology systems; the
Company’s ability to retain key members of management and
successfully integrate new executives; the Company’s ability to
complete acquisitions, strategic investments, entry into new lines
of business, divestitures, mergers or other transactions on
acceptable terms, or at all; potential risks and uncertainties
relating to the existing and ultimate impact of the COVID-19
pandemic, including actions that may be taken by governmental
authorities to contain the COVID-19 outbreak or to treat its
impact, and the potential negative impacts of COVID-19 on the
global economy and financial markets; the general economic impact
of the ongoing war in Ukraine, including the impact of related
sanctions being imposed by the U.S. Government and the governments
of other countries, and the impact of potential reprisals as a
consequence of the war in Ukraine and any related sanctions; and
other factors that may cause actual results to be materially
different from those described herein as anticipated, believed,
estimated or expected. Certain of these risks and uncertainties are
or will be described in greater detail in the Company’s Form 10-K
and Form 10-Q filings with the Securities and Exchange Commission,
which are available at http://www.sec.gov. Given the risks and
uncertainties, readers should not place undue reliance on any
forward-looking statement and should recognize that the statements
are predictions of future results which may not occur as
anticipated. Many of the risks listed above have been, and may
further be, exacerbated by the COVID-19 pandemic, including its
impact on the healthcare industry, or the ongoing war in Ukraine.
Actual results could differ materially from those anticipated in
the forward-looking statements and from historical results, due to
the risks and uncertainties described herein, as well as others not
now anticipated. CynergisTek is under no obligation (and expressly
disclaims any such obligation) to update or alter its
forward-looking statements whether as a result of new information,
future events, or otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220719005465/en/
CynergisTek Investor Relations Contact: CynergisTek, Inc.
Bryan Flynn (512) 402-8550 x7 InvestorRelations@cynergistek.com
CynergisTek Media Contact: CynergisTek, Inc. Trinity
McPherson (443) 853-8468 trinity.mcpherson@cynergistek.com
CynergisTek (AMEX:CTEK)
Historical Stock Chart
From Sep 2024 to Oct 2024
CynergisTek (AMEX:CTEK)
Historical Stock Chart
From Oct 2023 to Oct 2024